BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Emdeon Corporation (HLTH) Announces Acquisition of TC3 Health to Expand Payment Integrity Solutions


5/7/2012 12:05:21 PM

NASHVILLE, Tenn., May 7, 2012 /PRNewswire/ -- Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced its acquisition of TC3Health, Inc. The acquisition of TC3 expands Emdeon's already robust Payment Integrity solutions for healthcare payers to include new claims analytics tools from pre-adjudication through post-payment, as well as access to a broad out-of-network claims cost management solution.

Headquartered in Irvine, CA, TC3 is a leading provider of cost containment solutions, including payment integrity analytics, clinical code editing and out-of-network claims cost management to payers and claims administrators. TC3's leading fraud, waste and abuse and clinical code editing capabilities further bolster Emdeon's comprehensive suite of prospective and retrospective payment integrity solutions. Additionally, TC3's out-of-network claims cost management solution provides healthcare payers with access to one of the nation's largest aggregated preferred provider organization (PPO) networks.

"The combination of Emdeon's health information and connectivity network, connecting more than 1,200 payers, with TC3's technology and extensive PPO network delivers a comprehensive cost containment solution for our customers at a time when controlling costs is of paramount importance," said Gary Stuart, executive vice president of payer services for Emdeon.

"There has never been a time in healthcare when we've seen such universal agreement and intense focus on containing healthcare costs," said Rob Gerger, chief operating and financial officer for TC3. "Enabling TC3's solutions within Emdeon's already broad suite of payment integrity solutions will help healthcare payers control costs by efficiently identifying, processing and accurately paying only valid claims."

About TC3

TC3 is a leading provider of cost containment solutions, including payment integrity and out-of-network claims cost management, to U.S. healthcare payers. TC3 provides healthcare payers a total claims management solution that provides payment integrity and enables cost savings for healthcare payers. TC3 electronically integrates claims transaction systems with pre-payment fraud, waste and abuse overpayment identification technology, out-of-network claims management systems and data analytics and reporting tools. Healthcare payers benefit from state-of-the-art loss control systems delivered through a single connectivity source to prevent claims errors and overpayments.

About Emdeon

Emdeon is a leading provider of revenue and payment cycle management and clinical information exchange solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon's offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon's comprehensive suite of solutions, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle and clinical information exchange processes. For more information, visit www.emdeon.com.

Forward-Looking Statements

Statements made in this press release that express Emdeon's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Such statements include statements regarding the anticipated performance of the acquired business and the integration of the acquired business with Emdeon. Forward-looking statements also may include information concerning Emdeon's possible or assumed future results of operations, including descriptions of Emdeon's revenues, profitability, outlook and overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to Emdeon's operations and business environment, all of which are difficult to predict and many of which are beyond Emdeon's control. Although Emdeon believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Emdeon's actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including the risks discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and elsewhere in Emdeon's Annual Report for the year ended December 31, 2011, as well as any public reports, press releases, filings or other public statements made by Emdeon.

You should keep in mind that any forward-looking statement made by Emdeon herein, or elsewhere, speaks only as of the date on which made. Emdeon expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in Emdeon's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Emdeon Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES